Advertisement
Advertisement
U.S. Markets open in 6 hrs 32 mins
Advertisement
Advertisement
Advertisement
Advertisement

ARYx Therapeutics, Inc. (ARYX)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00050.0000 (0.00%)
At close: 08:32AM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/8/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.04
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.0023
52 Week Low 30.0001
50-Day Moving Average 30.0005
200-Day Moving Average 30.0004

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 533.46M
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 10.00%
% Held by Institutions 10.15%
Shares Short (Feb 27, 2011) 489.05k
Short Ratio (Feb 27, 2011) 40.79
Short % of Float (Feb 27, 2011) 4N/A
Short % of Shares Outstanding (Feb 27, 2011) 40.27%
Shares Short (prior month Jan 30, 2011) 495.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2009
Most Recent Quarter (mrq)Sep 29, 2010

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-74.86%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.18M
Net Income Avi to Common (ttm)-18.33M
Diluted EPS (ttm)-0.5920
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.95M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)11.57M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.47
Book Value Per Share (mrq)-0.23

Cash Flow Statement

Operating Cash Flow (ttm)-20.07M
Levered Free Cash Flow (ttm)-10.64M
Advertisement
Advertisement